Adaptimmune Therapeutics shares owned by Douglas Lane & Associates
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Douglas Lane & Associates
from 13F filings
Historical chart of Douglas Lane & Associates investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Douglas Lane & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Douglas Lane & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.7k | 11k | 0.79 |
| 2023-09-30 | $8.6k | 11k | 0.78 |
| 2023-06-30 | $12k | 13k | 0.93 |
| 2023-03-31 | $14k | 13k | 1.09 |
| 2022-12-31 | $19k | 13k | 1.46 |